Markus Voegtle
Active 2019–2023
- 5
- Papers
- 148
- Citations
- 5
- h-index
- 5
- i10-index
Self-citations are included in these numbers.
Citations per year
Citations
Citation sources
Countries
This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.
Institutions
- Chinese Academy of Sciences12.3%
- Novartis (Switzerland)11.9%
- Bayer (Germany)11.9%
- AstraZeneca (Sweden)10.2%
- Cold Spring Harbor Laboratory7.8%
- Shanghai Institute of Materia Medica6.6%
- Other39.3%
Fields
- Biochemistry, Genetics and Molecular Biology55.4%
- Medicine19.6%
- Computer Science12.5%
- Chemistry5.4%
- Pharmacology, Toxicology and Pharmaceutics3.6%
- Engineering1.8%
- Other1.8%
Topics
- Hippo pathway signaling and YAP/TAZ30.3%
- Computational Drug Discovery Methods11.2%
- Alzheimer's disease research and treatments9%
- Ubiquitin and proteasome pathways6.7%
- Cholinesterase and Neurodegenerative Diseases6.7%
- Protein Degradation and Inhibitors6.7%
- Other29.2%
Frequent coauthors
- Joerg Kallen4
- Clemens Scheufler3
- Emilie A. Chapeau3
- Holger Sellner3
- Markus Wartmann3
- Nicolas Soldermann3
- Pascal Furet3
- Patrick Chêne3
- Stephanie Harlfinger3
- Tobias Schmelzle3
- Bahaâ Salem2
- César Fernández Fernández2
- Eloísa Jiménez Núñez2
- Mickaël Le Douget2
- Vincent Bordas2
- Andreas Billich1
- Anne‐Laure Le Goff1
- Bérengère Dumotier1
- Cara E. Brocklehurst1
- Christian Beerli1
- Christine Guntermann1
- Christine Rouzet1
- Claudia Betschart1
- Daniel Bauer1
All papers
Loading papers…
